NCT00599131 Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) Status TERMINATED Phase PHASE2
NCT00580983 Optimized Intensity Modulated Irradiation for Head and Neck Cancer Status COMPLETED Phase NA
NCT00577057 Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer Status UNKNOWN Phase NA
NCT00570531 Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma Status TERMINATED Phase PHASE2
NCT00565448 Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents Status COMPLETED Phase PHASE2
NCT00563927 Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0) Status UNKNOWN Phase NA
NCT00563862 Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0) Status TERMINATED Phase NA
NCT00559845 A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT00555672 Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer Status COMPLETED Phase PHASE1
NCT00551759 Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer Status TERMINATED Phase PHASE2
NCT00548548 A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT00539617 Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery Status TERMINATED Phase PHASE2
NCT00526110 Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00525915 Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma Status COMPLETED Phase PHASE2
NCT00525785 Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) Status COMPLETED Phase PHASE2
NCT00515216 Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors Status COMPLETED Phase PHASE2
NCT00513383 Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck Status COMPLETED Phase PHASE1
NCT00510367 Primary Breast Cancer Occurring Concomitant With Pregnancy Status COMPLETED Phase EARLY_PHASE1
NCT00508872 Folfox-B Study for Patients With Colorectal Liver Metastases Status TERMINATED Phase PHASE2